Litcius/Paper detail

Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses

Nadereh Naderi, Mahsa Rahimzadeh

2021Virology29 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Meta-analysisInternal medicineBiomarkerCochrane LibrarySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineGastroenterologyDiseasePathologyBiologyInfectious disease (medical specialty)BiochemistryOutbreakCOVID-19 Clinical Research StudiesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisChemokine receptors and signaling
Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses | Litcius